Search results (1005)
« Back to NewsSalsa classes shown to reduce depressive symptoms in young adults
15 July 2026
A new trial led by the University of Oxford suggests it may offer a promising, accessible addition to youth wellbeing support.
Infections linked to higher risk of brain and mental health conditions for up to two years
15 July 2026
A large study of more than 1 million matched patient pairs has found that serious infections across the body are followed by increased risks of psychiatric and neurological diagnoses, especially in adults.
Study shows AI can be safely deployed in NHS prostate cancer diagnosis
15 July 2026
Findings from the landmark Articulate Pro study have now been published, marking a major milestone for the use of artificial intelligence (AI) in NHS histopathology laboratories and demonstrating its potential to improve and standardise prostate cancer diagnosis.
World’s first Phase I Bundibugyo ebolavirus vaccine trial launched by Oxford Vaccine Group
13 July 2026
The University of Oxford’s Oxford Vaccine Group has launched the world’s first Phase I clinical trial, BD-Ebov, of a vaccine against Bundibugyo ebolavirus (BDBV), in response to the ongoing outbreak in the Democratic Republic of the Congo and neighbouring Uganda.
World-first perfused pancreas transplant marks major Oxford study milestone
9 July 2026
A clinical study at the University of Oxford has recruited its first participant, marking the world’s first successful transplantation of a perfused human pancreas and a major advance in efforts to improve organ preservation for transplantation.
Professor Adrian Hill wins European Inventor Award 2026 for highly effective malaria vaccine
7 July 2026
The European Patent Office (EPO) has awarded Professor Sir Adrian Hill the European Inventor Award 2026 in the Research category for developing the R21/Matrix-M malaria vaccine.
The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences team wins Award for Excellence for transforming ulcerative colitis care
6 July 2026
The Sagittarius Team, a pioneering partnership between the University of Oxford and Oxford University Hospitals (OUH) has been recognised with the OUH Award for Excellence 2026 for transforming care for people experiencing a relapse of ulcerative colitis while advancing translational research.
Patient enrolment begins in PARTNERS trial to identify the first effective treatments for Bundibugyo virus disease
2 July 2026
Patient enrolment has begun in the Democratic Republic of the Congo for the PARTNERS clinical trial of treatments for Bundibugyo virus disease (BVD). The trial is led in the DRC by the Institute National pour la Recherche Biomedicale, supported by the Institute of Tropical Medicine in Belgium, Ministry of Public Health of the Democratic Republic of the Congo, ALIMA (The Alliance for International Medical Action) and outbreak response teams from Médecins Sans Frontières (MSF). International trial coordination is led by the Pandemic Sciences Institute at the University of Oxford.
Chellaram Foundation £5 million gift to Oxford launches new programme for healthy and sustainable diets
1 July 2026
A major new research and engagement programme at the University of Oxford will investigate how healthier, more sustainable diets can be achieved at population level, and how evidence can inform policy and practice across food, health and environmental systems.
Oxford researchers awarded ARIA funding to develop transformative anti-viral therapies
26 June 2026
Three innovative research projects aimed at transforming how we protect against respiratory viruses, led by teams at the University of Oxford, have secured funding through the UK’s Advanced Research and Invention Agency (ARIA).
New Oxford calculator shows serious statin muscle side effects are rare for most people
26 June 2026
Researchers at the Nuffield Department of Primary Care Health Sciences, University of Oxford, have developed a new calculator that estimates a person's risk of developing serious muscle disorders from statins. The tool could help patients and clinicians make more informed decisions about using these widely prescribed medications to prevent heart attacks and strokes.
Smoking and drinking exacerbate social inequalities in premature deaths in India
25 June 2026
Study finds social inequality is a major predictor of premature death, even among people who neither smoke nor drink alcohol.
Oxford research showcased at House of Commons pancreatic cancer event
25 June 2026
Mr Keaton Jones, Senior Clinical Researcher at the Nuffield Department of Surgical Sciences, attended 'Driving Treatment Breakthroughs', a Pancreatic Cancer UK parliamentary reception held at the House of Commons on 16 June 2026.
The University of Oxford and King’s College London join IMPACT network study to advance understanding of profound autism
24 June 2026
The University of Oxford and King’s College London (King’s) have joined the Innovative Medicine and Precision Approaches to Clinical Trials (IMPACT) Network, an international collaboration of sites working together to accelerate clinical trial readiness and therapeutic development for autism through a large-scale natural history and clinical endpoint study.
Study reveals rare genetic variants that shape unexpected traits and health outcomes
23 June 2026
New study reveals why some people defy genetic expectations, offering insights into rare diseases and future treatments.
Natural compound may help boost vaccine responses in older adults
23 June 2026
Researchers from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) have found that a naturally occurring compound called spermidine may help improve vaccine responses in some older adults by reducing signs of immune system ageing.
Equal funding transformed GP teaching, first evidence finds – now its gains need protecting
22 June 2026
The first study of England's harmonised education tariff finds equal funding has expanded GP placements and strengthened teaching quality – and identifies what must be protected as NHS England's functions transfer to the Department of Health and Social Care.
Kneecap resurfacing during knee replacement should be the standard procedure, new study finds
17 June 2026
The largest and longest clinical trial of its kind has found that resurfacing the kneecap during total knee replacement is likely to be the most cost-effective approach for patients and healthcare systems over the long term.
Warneford Park: Mental health and medical research campus development gets green light from Oxford City Council
17 June 2026
Plans to create a £750m mental health and medical research campus in Oxford have been given the go-ahead by Oxford City Council.
New Oxford Centre for Women’s Mental Health established
17 June 2026
The University of Oxford is set to launch a new research centre dedicated to women’s mental health, bringing together expertise from medical and biological sciences with humanities for the first time.